The Roswell (2021)

The Roswell ME Chip™ is the first to cross the frontier of digital biology — we just created their visual assets, website, and rebranded their company.

Paul Mola and Barry Merriman founded Roswell Biotechnologies in 2014. As veterans of genomic sequencing, they understood that precision medicine would fail to live up to its promise without a new technology to carry it over the threshold of its diagnostic limitations.

As Roswell Biotech, they created a computational architecture that not only incorporates the precision of biology through its direct application (no machine learning approximations and “AI” simulations), but one that also utilizes the immense potential of being easily scalable and applicable to existing software and digital technologies.

More at: fiftyseven.co/case/roswell-biotech